AMPX

Amprius Technologies, Inc.

$15.49

-7.91%
Jun 16, 2026
Bobby Quantitative Model
Amprius Technologies, Inc. is a developer and manufacturer of high-energy-density lithium-ion batteries utilizing silicon anode technology, operating within the Electrical Equipment & Parts industry. The company positions itself as a technology disruptor, offering a direct drop-in replacement for traditional graphite anodes, targeting demanding mobility applications in aviation, electric vehicles, and drones. The current investor narrative is heavily focused on the validation of its technology through commercial scaling, as evidenced by surging revenue growth and recent news highlighting record trading volume as a signal of strong fundamental interest and near-term upside potential.

People also watch

Vertiv

Vertiv

VRT

Analysis
Bloom Energy

Bloom Energy

BE

Analysis
Ametek

Ametek

AME

Analysis
Hubbell Incorporated

Hubbell Incorporated

HUBB

Analysis
Advanced Energy

Advanced Energy

AEIS

Analysis

BobbyInvestment Opinion: Should I buy AMPX Today?

Rating: Hold. The core thesis is that AMPX possesses a validated, high-growth technology story but trades at a valuation that demands perfection, creating an unfavorable risk/reward balance at current levels despite unanimous analyst bullishness.

The explosive 137% YoY revenue growth and rapid gross margin improvement from negative to 23.65% are compelling and justify a premium. However, this premium is extreme, with a forward EV/Sales of 26.21 and a trailing P/S of 13.47. The stock is also highly volatile (beta 2.135) and has corrected -6.91% over the past month. While analyst sentiment is uniformly positive, the implied growth expectations embedded in the valuation leave minimal room for error.

The thesis would upgrade to Buy if the forward EV/Sales multiple compressed below 15x while revenue growth sustained above 100%, or if the company reported a sequential quarter of positive operating cash flow. It would downgrade to Sell if quarterly revenue growth decelerated sharply below 50% or if gross margins retreated back towards zero. Relative to its own history, the valuation has compressed but remains high; relative to peers (data unavailable), it is likely at a significant premium. The stock is overvalued based on current financials but fairly valued only if its hyper-growth trajectory is sustained for multiple years.

Sign up to view all

AMPX 12-Month Price Forecast

AMPX is a classic high-risk, high-potential growth story at an inflection point. The evidence of commercial scaling (137% revenue growth, positive gross margin) is compelling and justifies analyst optimism. However, the current price fully reflects this success and requires near-perfect execution for years to come. The high beta of 2.135 and recent correction signal investor nervousness about these elevated expectations. The stance is neutral, as the strong fundamentals are counterbalanced by extreme valuation. Confidence is medium due to limited analyst coverage and the company's pre-profitability stage. The stance would upgrade to bullish on evidence of sustained margin expansion above 30% or a major customer announcement. It would turn bearish on a material deceleration in revenue growth below 70%.

Historical Price
Current Price $15.49
Average Target $20
High Target $30
Low Target $8

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Amprius Technologies, Inc.'s 12-month outlook, with a consensus price target around $20.14 and implied upside of +30.0% versus the current price.

Average Target

$20.14

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$12 - $20

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage appears limited but uniformly bullish among the firms providing recent ratings. The institutional ratings data shows a consistent pattern of 'Buy' or 'Overweight' actions from firms including Needham, B. Riley Securities, Craig-Hallum, Cantor Fitzgerald, and Roth Capital throughout 2025 and into March 2026, with no downgrades noted. While a precise consensus target price and implied upside are not calculable from the provided data, the unwavering bullish sentiment from covering analysts, coupled with recent news citing 'significant near-term upside potential,' strongly suggests a positive consensus. The absence of bearish ratings indicates high conviction among the limited analyst community, though the small number of covering firms (3 analysts according to the analyst data) also implies this is still a stock with limited institutional coverage, which can contribute to its high volatility.

Drowning in data?

Find the real signal!

Bulls vs Bears: AMPX Investment Factors

The bull case, centered on explosive 137% YoY revenue growth and a clear path to positive gross margins (23.65%), is currently supported by stronger near-term evidence of commercial execution. However, the bear case, anchored by an extreme forward EV/Sales of 26.21 and persistent, deep losses, presents a formidable counter-argument on valuation sustainability. The single most important tension in the investment debate is whether the company's blistering revenue growth can accelerate fast enough to justify its premium valuation before cash burn or a growth slowdown triggers a severe derating. The recent price correction and high beta of 2.135 underscore the binary, high-risk/high-reward nature of this bet on scaling a pre-profitability technology.

Bullish

  • Explosive Revenue Growth: Q4 2025 revenue of $25.2 million grew 137.36% YoY, accelerating from $11.3 million in Q1 2025, demonstrating successful commercial scaling of its silicon anode technology. This multi-quarter sequential growth validates the core investment thesis of market adoption.
  • Rapidly Improving Gross Margins: Gross margin turned positive to 23.65% in Q4 2025, a dramatic improvement from negative margins in 2024. This indicates the company is moving down the cost curve and establishing a path toward eventual profitability as production scales.
  • Unanimous Analyst Bullishness: All covering analysts (Needham, B. Riley, Craig-Hallum, etc.) maintain Buy/Overweight ratings, with no downgrades noted. This high-conviction sentiment, coupled with news citing 'significant near-term upside potential,' suggests strong institutional belief in the growth story.
  • Strong Balance Sheet for Growth: A current ratio of 7.08 and a manageable debt-to-equity of 0.38 provide ample liquidity to fund the current cash-burn phase. The $90.5 million cash position at Q4 2025 end offers a runway to execute its scaling plan without immediate dilution risk.

Bearish

  • Extreme Valuation on Forward Sales: The forward EV/Sales ratio of 26.21 is exceptionally high, pricing in near-perfect execution of massive future growth. This leaves the stock vulnerable to severe multiple compression if revenue growth decelerates or margins fail to expand as anticipated.
  • Persistent and Significant Losses: The company reported a Q4 2025 net loss of -$24.4 million and a trailing FCF of -$35.5 million. Despite revenue growth, profitability remains elusive, and the path to sustained positive cash flow is unproven and capital-intensive.
  • Extreme Volatility and Recent Weakness: With a beta of 2.135, AMPX is more than twice as volatile as the market. Recent momentum has turned sharply negative, with a 1-month return of -6.91% and a 3-month return of -9.14%, diverging from the long-term uptrend and signaling a corrective phase.
  • High Cash Burn Rate: Quarterly operating cash flow was -$3.5 million. At this burn rate, the $90.5 million cash balance provides a finite runway, raising the risk of future equity dilution to fund operations if profitability is not achieved on schedule.

AMPX Technical Analysis

The stock is in a powerful long-term uptrend but has recently entered a corrective phase. The 1-year price change of +313.96% is extraordinary, yet the current price of $16.31 sits at approximately 67% of its 52-week range ($3.43 to $24.225), indicating a significant retreat from recent highs and suggesting a potential consolidation or profit-taking phase after a parabolic rise. Recent momentum has turned sharply negative, diverging from the long-term trend. The 1-month price change is -6.91% and the 3-month change is -9.14%, contrasting with the positive 6-month change of +49.50%. This divergence signals a short-term correction, which is further evidenced by the stock's extreme volatility, with a beta of 2.135 indicating it is more than twice as volatile as the broader market. Key technical levels are clearly defined by the 52-week high of $24.225 and low of $3.43. A breakout above the recent high resistance would signal a resumption of the primary uptrend, while a breakdown below key support near the $15 level (evident from recent price action) could trigger a deeper correction toward the $12-$13 zone. The high beta necessitates careful risk management for investors.

Beta

2.13

2.13x market volatility

Max Drawdown

-46.4%

Largest decline past year

52-Week Range

$3-$24

Price range past year

Annual Return

+279.7%

Cumulative gain past year

PeriodAMPX ReturnS&P 500
1m-8.1%+1.5%
3m-18.0%+13.4%
6m+69.3%+10.9%
1y+279.7%+24.5%
ytd+77.2%+10.0%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

AMPX Fundamental Analysis

Revenue growth is accelerating dramatically, signaling successful commercial adoption. The most recent quarterly revenue for Q4 2025 was $25.234 million, representing a massive year-over-year growth rate of 137.36%. This growth is part of a clear multi-quarter acceleration, as revenue has increased sequentially from $11.284 million in Q1 2025 to the current level. This explosive trajectory is the core of the bullish investment case, indicating the company is moving beyond the R&D phase. However, profitability remains elusive, with a net income of -$24.391 million and a gross margin of 23.65% for the latest quarter. While still negative, the gross margin of 23.65% shows a stark improvement from the negative gross margins reported in 2024, indicating a path toward eventual profitability as scale improves. The balance sheet shows a strong liquidity position but significant cash burn. The current ratio is a robust 7.08, and debt-to-equity is a manageable 0.38. However, trailing twelve-month free cash flow is deeply negative at -$35.534 million, and the latest quarterly operating cash flow was -$3.497 million, indicating the company is still reliant on external financing to fund its growth and operations despite its $90.5 million cash position at the end of Q4 2025.

Quarterly Revenue

$25234000.0B

2025-12

Revenue YoY Growth

+1.37%

YoY Comparison

Gross Margin

+0.23%

Latest Quarter

Free Cash Flow

$-35534000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Open an Account, get $2 TSLA now!

Valuation Analysis: Is AMPX Overvalued?

Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 13.47, while the forward-looking metric, EV-to-Sales, is 26.21. The significant gap between these figures implies the market is pricing in very high expectations for future revenue growth and margin expansion. Peer comparison data is not available in the provided dataset, preventing a direct sector premium/discount analysis. Historically, the stock's own valuation has compressed significantly as revenue has scaled. The current PS ratio of 13.47 is far below its historical highs seen in 2023 and early 2024, which exceeded 100x. This compression suggests the market is now valuing the company more on its actual growth trajectory rather than pure speculative potential, though the forward EV/Sales of 26.21 still indicates optimistic growth expectations are baked into the price.

PE

-22.3x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -148x~-2x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-23.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are pronounced. AMPX is a pre-profitability company burning significant cash, with a trailing FCF of -$35.5 million and a Q4 2025 net loss of -$24.4 million. While the $90.5 million cash balance provides a runway, the -$3.5 million quarterly operating cash outflow indicates continued reliance on external capital. Revenue, while growing rapidly at 137% YoY, is still small at $25.2 million per quarter, and the company's path to sustained positive net income remains unproven, creating earnings volatility risk.

Market & Competitive Risks are elevated due to its premium valuation and high volatility. Trading at a forward EV/Sales of 26.21, the stock is priced for flawless execution of hyper-growth. Any deceleration in the 137% growth rate or margin expansion could trigger severe multiple compression, as seen historically when its P/S collapsed from >100x to 13.47. The beta of 2.135 means it is highly sensitive to broader market swings and risk-off sentiment, which could disproportionately impact its valuation. As a technology disruptor in batteries, it also faces intense competition from established players and alternative technologies.

The Worst-Case Scenario involves a combination of growth deceleration and sustained losses leading to a liquidity crisis. If quarterly revenue growth slows below 50% while gross margins stagnate, the high-flying valuation could unravel. This could trigger analyst downgrades, a loss of investor confidence, and a flight to safety. A realistic downside could see the stock re-test its 52-week low of $3.43, representing a potential loss of approximately -79% from the current price of $16.31. A more probable severe bear case might see a decline to the $8-$10 range, a -35% to -50% drawdown, aligning with support levels broken during the recent correction and reflecting a derating to a still-high but more reasonable sales multiple for a growth company.

FAQ

The key risks are, in order of severity: 1) Valuation & Execution Risk: The high forward EV/Sales of 26.21 makes the stock vulnerable to severe multiple compression if revenue growth decelerates from its current 137% rate. 2) Financial Risk: The company is not profitable, with a Q4 net loss of -$24.4M and negative FCF of -$35.5M TTM, requiring external funding. 3) Market & Volatility Risk: With a beta of 2.135, the stock is more than twice as volatile as the market, leading to amplified swings during broader downturns. 4) Competitive & Technological Risk: As a disruptor in the battery space, it faces competition from established players and the risk that its silicon anode technology may not achieve widespread commercial adoption as anticipated.

The 12-month outlook for AMPX is bifurcated, with a high degree of uncertainty reflected in its wide potential price range. The base case (50% probability) sees the stock trading between $18 and $22, assuming robust but moderating revenue growth and gradual margin improvement. The bull case (30% probability) projects a surge to $24-$30 on the back of sustained hyper-growth and a major commercial breakthrough. The bear case (20% probability) warns of a decline to $8-$12 if growth decelerates sharply and valuation compresses. The most likely scenario is the base case, which assumes the company continues to execute well but the extreme valuation moderates as growth naturally decelerates from its current torrid pace. The key assumption is that quarterly revenue growth remains above 70%.

AMPX appears overvalued based on traditional metrics but may be fairly valued if its hyper-growth trajectory is sustained. The primary valuation metric, forward EV/Sales, stands at 26.21, which is extremely high and implies the market expects revenue to grow exponentially for the foreseeable future. The trailing P/S of 13.47, while lower, is still a premium multiple. Compared to its own history, where the P/S once exceeded 100x, the valuation has compressed significantly as revenue has scaled, suggesting the market is now pricing growth more rationally. Without peer data, a direct comparison is difficult, but the multiple is undoubtedly at the high end for industrial companies. The valuation implies the market expects near-perfect execution of its scaling plan and rapid margin expansion.

AMPX is a high-risk, high-reward investment that is not suitable for all investors. For aggressive growth investors with a long-term horizon and high risk tolerance, the stock offers exposure to a potentially disruptive battery technology with proven commercial traction, as evidenced by 137% YoY revenue growth. However, at a forward EV/Sales of 26.21, the valuation demands flawless execution for years. The unanimous analyst bullishness is a positive signal, but the stock's extreme volatility (beta 2.135) and recent correction of -6.91% over one month highlight its speculative nature. It could be a good buy on significant pullbacks for those who believe in the long-term story, but it is a Hold at current levels due to the rich valuation.

AMPX is unequivocally a long-term investment, with a suggested minimum holding period of 3-5 years. The company is in a capital-intensive scaling phase with no current profits or dividends, making it unsuitable for income or short-term trading for most investors. Its extreme volatility (beta 2.135) and high valuation based on future growth prospects mean short-term price movements are likely to be noisy and driven by sentiment rather than fundamentals. The investment thesis is predicated on the company successfully scaling its technology and achieving profitability over multiple years. Only investors with a long-term horizon can reasonably weather the inevitable volatility and wait for the fundamental story to fully play out.